The Medicines Company Sells Infectious Disease Unit
By Natasha Piper
Pharma Deals Review: Vol 2017 Issue 12 (Table of Contents)
Published: 8 Dec-2017
DOI: 10.3833/pdr.v2017.i12.2289 ISSN: 1756-7874
Section: Mergers & Acquisitions
Fulltext:
Abstract
The Medicines Company has sold its infectious disease business, which it had built up in recent years with the acquisitions of Targanta Therapeutics and Rempex, to Melinta Therapeutics for US$270 M...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS